SYRE – spyre therapeutics, inc. (US:NASDAQ)

News

Spyre Therapeutics (SYRE): Favorite Stock of Elite Money Managers [Yahoo! Finance]
Spyre Therapeutics (SYRE) was downgraded by Wall Street Zen from "hol
Here's What Raymond James Says About Spyre Therapeutics Inc (SYRE) [Yahoo! Finance]
Spyre Therapeutics (SYRE) had its price target raised by JonesTrading from $64.00 to $95.00. They now have a "buy" rating on the stock.
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com